Bayesian Capital Management’s Kirby Corp KEX Stock Holding History

Bayesian Capital Management’s Portfolio KEX Stock Details KEX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,513	Closed	-$210K	–	335
2025 Q3	$210K	Buy	+2,513	New	+$252K	0.04%	452
2019 Q3	–	Sell	-8,024	Closed	-$634K	–	604
2019 Q2	$634K	Buy	+8,024	New	+$644K	0.13%	216

Other funds holding KEX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bayesian Capital Management's KEX Position: Q4 2025 in Review

Bayesian Capital Management sold out of Kirby Corp (KEX) in Q4 2025, closing a stake of 2,513 shares — an estimated $210K sold.

Bayesian Capital Management first reported a position in KEX in Q2 2019 and held it in 2 quarters. The position peaked at $634K in Q2 2019. 411 funds tracked by Wall St. Rank hold KEX as of Q4 2025.

Bayesian Capital Management reported no remaining Kirby Corp position as of Q4 2025 after selling out during the quarter.
Bayesian Capital Management sold 2,513 Kirby Corp shares in Q4 2025, an estimated $210K.
Bayesian Capital Management first reported a position in Kirby Corp in Q2 2019 and held it in 2 quarters.
Bayesian Capital Management's Kirby Corp position peaked at $634K in Q2 2019.
411 funds tracked by Wall St. Rank held Kirby Corp as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.